Vext to Announce Financial Results for Q1 2024 on May 29, 2024
Vext Science (CSE: VEXT, OTCQX: VEXTF), a U.S.-based cannabis operator in Arizona and Ohio, announced it will release its Q1 2024 financial results on May 29, 2024, before market open.
The results will cover the quarter ended March 31, 2024.
A conference call and webcast will follow at 8:00 a.m. ET on the same day.
Dial-in numbers for the call are +1-647-484-8814 or 1-844-763-8274, with a replay available until June 12, 2024, at +1-604-674-8052 or 1-855-669-9658, using conference ID 10023534.
Webcast access is provided through https://www.gowebcasting.com/13356. For further details, contact investors@vextscience.com.
- Vext Science will release financial results, providing transparency to investors.
- Conference call and webcast offer direct communication with stakeholders.
- Replay access until June 12, 2024, ensures availability of information for all investors.
- No preliminary financial data or performance indicators provided ahead of results.
- Investors must wait until May 29 for detailed financial performance insights.
Vancouver, British Columbia--(Newsfile Corp. - May 24, 2024) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, today announced that it plans to release its financial results for the first quarter ended March 31, 2024, before market open on May 29, 2024.
The Company will host a conference call and webcast on the same day, Wednesday, May 29, 2024, at 08:00 a.m. ET.
CONFERENCE CALL DETAILS
Date: May 29, 2024 | Time: 8:00 am ET
Participant Dial-in: +1-647-484-8814 or 1-844-763-8274
Replay Dial-in: +1-604-674-8052 or 1-855-669-9658
Conference ID: 10023534
Playback #: 0924 (Expires on June 12, 2024)
Listen to webcast: https://www.gowebcasting.com/13356
A replay of the conference call and webcast will be available on Vext's investor website following the conclusion of the call. For more details, contact the IR team at investors@vextscience.com.
About Vext Science, Inc.
Vext Science, Inc. is a U.S.-based cannabis operator with vertical operations in Arizona and Ohio. Vext's expertise spans from cultivation through to retail operations in its key markets. Based out of Arizona, Vext owns and operates state-of-the-art cultivation facilities, fully built-out manufacturing facilities as well as dispensaries in both Arizona and Ohio. The Company manufactures Vapen™, one of the leading THC concentrates, edibles, and distillate cartridge brands in Arizona. Its selection of award-winning products are created with Vext's in-house, high-quality flower and distributed across Arizona and Ohio, as well as through Vext's partnerships in other states. Vext's leadership team brings a proven track record of building and operating profitable multi-state operations, with the Company having operated profitably since 2016. The Company's primary focus is to continue growing in its core states of Arizona and Ohio, bringing together cutting-edge science, manufacturing, and marketing to provide a reliable and valuable customer experience while generating shareholder value.
Vext Science, Inc. is listed on the Canadian Securities Exchange under the symbol VEXT and trades on the OTCQX market under the symbol VEXTF. Learn more at www.vextscience.com and connect with Vext on Twitter/X and LinkedIn.
For more details on the Vapen brand:
Vapen website: VapenBrands.com
Instagram: @vapen
Facebook: @vapenbrands
Forward-Looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Vext's periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.
Forward-looking statements may include, without limitation, statements regarding the expected filing date of the financial results, future developments and the business and operations of Vext, all of which are subject to the risk factors contained in Vext's continuous disclosure filed on SEDAR+ at www.sedarplus.ca.
Although Vext has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; being engaged in activities currently considered illegal under U.S. Federal laws; change in laws; reliance on management; requirements for additional financing; competition; hindered market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.
There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. Because of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Vext disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Vext does not assume any liability for disclosure relating to any other company mentioned herein.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
Eric Offenberger
Chief Executive Officer
844-211-3725
For further information:
Jonathan Ross, Vext Investor Relations
jon.ross@loderockadvisors.com
416-244-9851
SOURCE: Vext Science, Inc
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/210397
FAQ
When will Vext Science announce its Q1 2024 financial results?
What time is the Vext Science Q1 2024 earnings call?
How can I access the Vext Science Q1 2024 earnings webcast?
What is Vext Science's stock symbol?
What is the conference ID for the Vext Science Q1 2024 earnings call replay?
Until when is the Vext Science Q1 2024 earnings call replay available?
